Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA Planning Another Patient Group To Boost Involvement

Executive Summary

Patient Engagement Collaborative expected to invite stakeholders to discuss how patient interaction with FDA can improve.

You may also be interested in...



US FDA's Patient Affairs Office Is An Office … In Spirit

Rachel Sherman says agency is creating patient affairs staff, but will not undergo reorganization to create an official office.

Patient Advocates Continue To Push US FDA For Central Office

Will a meeting with the agency's new principal deputy commissioner help assure creation of new access point for patient engagement?

US FDA Patient Affairs Office Could Accelerate Involvement With 'Central Entry Point'

FDA floats idea of central office to coordinate patient engagement for symbolic as well as practical reasons.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

ID1128360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel